The 10% General Rule: An Expert Analysis of the Delaware Research and Development Tax Credit (Method A)

I. Executive Summary: The Delaware 10% R&D Credit Defined

The 10% Credit Rate is the general calculation rule (Method A) for the Delaware Research and Development (R&D) Tax Credit, as defined in Title 30, Chapter 20, Subchapter VIII of the Delaware Code.1 It is calculated as 10% of the taxpayer’s Delaware Qualified Research Expenses (QREs) that exceed a statutory, historically derived “Delaware Base Amount,” subject to a 50% statutory floor.2

This incentive is a powerful cash flow tool for businesses investing in innovation within the state, as any resulting credit that is unused due to insufficient tax liability is fully refundable by the Delaware Division of Revenue (DOR).4

Key Takeaways for Taxpayers

The 10% General Rule requires taxpayers to navigate complex historical expenditure calculations distinct from the federal system. Key operational considerations include:

  • Method A Calculation Complexity: The 10% rate utilizes the detailed “Fixed-Base Percentage” (FBP) methodology, mirroring the structure of the Federal Regular Research Credit (RRC), but requires applying this methodology exclusively to Delaware-apportioned historical data.3
  • The 50% Constraint: A mandatory statutory floor dictates that the eligible credit-earning base cannot exceed 50% of the current year’s total Delaware Qualified Research Expenses (QREs). This constraint reinforces the credit’s focus on rewarding incremental spending.3
  • Strategic Flexibility and Compliance: The determination of which Delaware R&D calculation method (Method A or Method B) to use is an annual election, completely independent of the choice made on the taxpayer’s federal return. This provides crucial strategic flexibility, but requires independent, rigorous modeling of both methods each year.6

II. Statutory Foundation and Context: Del. Code Ann. tit. 30, § 2070

A. Introduction to the Research and Development Tax Credit

The Delaware R&D tax credit is a cornerstone state incentive codified under Title 30, Chapter 20, Subchapter VIII of the Delaware Code.1 This legislation aims to stimulate in-state innovation by providing relief for qualified expenditures. The statute offers taxpayers two distinct methods for calculating the credit, allowing for optimization based on the taxpayer’s R&D expenditure history and growth rate: the General Rule (Method A), which uses a 10% rate based on historical fixed percentage, and Method B, which uses a 50% rate based on the federal Alternative Simplified Credit (ASC).6

B. Detailed Meaning of the 10% General Rule (Method A)

The 10% rate is the default and baseline calculation mechanism established for taxpayers who do not qualify as small businesses—that is, those with average annual gross receipts exceeding the $\$20$ million threshold.1

Statutorily, the calculation is defined as the credit being equal to: 10% of the excess of the taxpayer’s total Delaware qualified research and development expenses for the taxable year over the taxpayer’s Delaware base amount.1 This structure ensures that the credit is not merely a subsidy for maintaining existing research levels but is designed specifically to reward the growth or increment in QREs compared to a complex, historically derived benchmark.

C. The Annual, Independent Election and Conformity to IRC § 41

Delaware mandates that the election of the state credit determination method (Method A or Method B) is an annual election, distinct from and independent of the method utilized for the federal R&D tax credit determination.6 This independence is a key feature, enabling sophisticated tax planning where a taxpayer might leverage the federal ASC (for its simplified base calculation) while simultaneously using the Delaware 10% General Rule (Method A) if it yields a superior state credit.

However, while the calculation method is independent, the underlying principles of qualification are intrinsically linked to federal law. Delaware requires that all underlying definitions of “qualified research” and “qualified research expenses” (QREs) adhere strictly to the guidelines set forth in Section 41 of the Internal Revenue Code (IRC).4 Crucially, only research activity that is physically conducted within the state of Delaware qualifies for the state credit.5

The decision by Delaware’s legislature to incorporate the complex federal Regular Research Credit (RRC) structure (the Fixed-Base Percentage method) into Method A, alongside the simpler federal Alternative Simplified Credit (ASC) structure in Method B, creates a necessary level of compliance sophistication. Because the Method A calculation demands accurate, state-specific data—Delaware QREs and Gross Receipts—over a four-year preceding period, it necessitates significant allocation and apportionment work.3 This detailed data requirement suggests that Method A is strategically designed for larger entities with robust accounting and compliance departments, who are best equipped to leverage the nuanced mechanics of the RRC calculation structure.

III. Dissecting the General Rule Calculation Mechanics

The calculation of the 10% General Rule is a highly prescriptive, multi-step process mandated by the Delaware Division of Revenue (DOR) through Form 2070AC.3

A. Defining Delaware Qualified Research Expenses (QREs)

The foundation of the credit calculation is the determination of Delaware QREs. These expenses must meet the rigorous standards for qualified research defined under IRC $\S 41$.7 This generally includes wages paid for research activities, costs of supplies used in research, and certain amounts paid for contract research.7 Critically, for the Delaware credit, these expenses are limited strictly to costs incurred for qualified research that is physically conducted within the state of Delaware.5 These Delaware QREs are utilized both as the current-year spending figure (Line 6) and as part of the historical data used to establish the Base Amount (Line 1).3

B. Calculation of the Delaware Base Amount (Form 2070AC, Line 5)

The Delaware Base Amount represents the historical R&D spending threshold that must be surpassed in the current year to generate the incremental credit.

1. Calculating the Fixed-Base Percentage (FBP)

The Fixed-Base Percentage (FBP) measures the historical intensity of the taxpayer’s R&D activities relative to its gross receipts within Delaware.

  • Data Requirement: The calculation requires the total Delaware QREs for the four years immediately preceding the credit year (entered on Line 1 of Form 2070AC) and the total Delaware Gross Receipts for the same four-year period (entered on Line 2).3
  • Formula (Line 3): The Delaware Fixed Based Percentage is calculated by dividing Line 1 (Total Prior 4-Year QREs) by Line 2 (Total Prior 4-Year Gross Receipts).3
  • Rules for New Entrants: If a taxpayer has fewer than four years of data, the calculation utilizes the available years. In the absence of any historical data, the fixed-base percentage is treated as zero.4

2. Determining Average Annual Gross Receipts (AAGR)

The Average Annual Gross Receipts (AAGR) scales the fixed-base percentage to the current economic activity of the taxpayer.

  • Data Requirement: The calculation uses the total Delaware Gross Receipts from the four years preceding the credit year (Line 2).3
  • Formula (Line 4): The AAGR is determined by dividing Line 2 by four (or by the actual number of preceding years if less than four).3 All gross receipts must conform to Delaware’s specific apportionment rules.4

3. Final Delaware Base Amount

The Base Amount is calculated by applying the derived FBP to the AAGR.

  • Formula (Line 5): Delaware Base Amount = Delaware Fixed Based Percentage (Line 3) $\times$ Average Annual Gross Receipts (Line 4).3

C. Application of the Statutory 50% Floor

The Base Amount establishes the minimum historical expenditure that cannot be credited. The subsequent calculation of the credit-earning base is then subject to a critical statutory cap: the 50% floor.

1. Calculating Excess QREs (Form 2070AC, Line 7)

The first step is determining the raw incremental spending.

  • Excess QREs = Current Year Delaware QREs (Line 6) – Delaware Base Amount (Line 5).3
  • If the Base Amount exceeds current-year QREs, the result is zero or less, and zero is entered on Line 7, resulting in no credit under Method A.3

2. Calculating the 50% Floor Constraint (Form 2070AC, Line 8)

The statutory constraint ensures that no more than half of the current year’s R&D expenditure can generate a credit.

  • The 50% Floor = Current Year Delaware QREs (Line 6) $\times$ 50%.3

3. Determining the Credit-Earning Base (Form 2070AC, Line 9)

The final amount subject to the 10% rate is the lower of the incremental spending or the statutory cap.

  • The credit-earning base is the smaller of the Excess QREs (Line 7) or the 50% Floor (Line 8).3

4. Final Credit Determination (Form 2070AC, Line 10)

  • Delaware R&D Credit = Credit-Earning Base (Line 9) $\times$ 10%.3

For high-growth, R&D-intensive companies that are the primary targets of this incentive, the 50% floor frequently operates as the effective constraint on the credit. When a company’s historical fixed-base percentage is low (due to low prior spending or rapid recent expansion), the calculated Excess QREs (Line 7) will often surpass 50% of the current QREs (Line 8). In these common scenarios, the credit-earning base defaults to the 50% floor. This structural mechanism effectively caps the maximum credit a large business can achieve under Method A at 5% of its total current-year Delaware QREs (10% applied to 50% of QREs). While this prevents excessive subsidization of baseline research, it requires taxpayers to rigorously evaluate whether the Alternative Simplified Credit (Method B) might offer a higher benefit relative to total spending.

IV. Delaware Division of Revenue (DOR) Guidance and Compliance

The administrative guidance issued by the Delaware Division of Revenue translates the statutory calculations of Title 30 into mandatory filing procedures. Strict adherence to these procedural requirements is essential, particularly due to the unique feature of refundability.

A. The Application and Filing Requirements

Taxpayers seeking the credit must file a formal application with the DOR.

  • Mandatory Form Usage: Taxpayers must utilize Delaware Form 2070AC (Application for Research and Development Tax Credit) to compute and claim the credit.3 Once the DOR authorizes the credit amount calculated on Form 2070AC, that amount must be transferred to the relevant line on the taxpayer’s annual state income tax return (e.g., Delaware Form 700).8 Both forms must be included with the granted annual income tax return.8
  • Substantiation Requirements: To demonstrate that the QREs meet the federal standards required by Delaware statute, the application requires the attachment of the Federal Form 6765. In cases where a consolidated corporate income tax return is filed federally, the taxpayer must attach a proforma Form 6765 specifically for the corporate applicant seeking the Delaware credit.3 This dual requirement ensures that the technical qualification of the expenses aligns with IRC $\S 41$ standards, even though the final state calculation (Method A) is distinct from the federal methodology.

B. Critical Administrative Deadline

The refundability of the credit is tied to a specific, critical filing deadline.

  • The September 15th Deadline: Qualified taxpayers must submit their application to the Division of Revenue on or before September 15 following the end of the taxable year during which the qualified R&D expenses were incurred.5 This deadline is a significant procedural element, as failure to meet it can jeopardize access to the refundable component of the incentive. Due to this specific deadline, taxpayers must manage their R&D credit application calendars independently of standard corporate income tax return filing or extension dates.

C. Refundability: The Key Strategic Advantage

A central policy objective of the Delaware R&D credit is realized through its designation as a fully refundable incentive.4

  • Financial Impact: Unlike non-refundable credits, which can only offset state income tax liability and may require lengthy carryforward periods if the taxpayer experiences a loss, Delaware guarantees a cash payout. Any portion of the tax credit that exceeds the taxpayer’s Delaware tax liability will be paid directly to the taxpayer in the form of a tax refund.4
  • Value to Innovators: This feature profoundly impacts the financial value of the credit, especially for R&D-intensive enterprises that are in the development stage, generating losses, or experiencing rapid scaling. By offering immediate working capital, the state shifts the credit from a mere future tax mitigation tool to a predictable, current-year revenue source tied to R&D investment. This enhanced certainty can significantly accelerate the internal rate of return (IRR) on qualified research projects and inform critical resource allocation decisions for corporate management.

V. Strategic Context: 10% General Rule vs. Alternatives

The independent, annual election requirement compels taxpayers to conduct detailed modeling comparing the 10% General Rule (Method A) against the other rates available under the Delaware statute.

A. The Small Business Enhancement (20% Rate)

Delaware provides an explicit, enhanced rate for smaller enterprises to maximize the incentive for emerging innovators.

  • Definition: The term “small business” is precisely defined as any taxpayer whose average annual gross receipts, determined by IRC $\S 41(c)(1)(B)$, do not exceed the applicable threshold of $20,000,000.1
  • Enhanced Method A Rate: For businesses that meet this definition, the 10% rate in Method A is effectively doubled and substituted with 20% of the excess QREs over the Delaware base amount.1 This high rate dramatically increases the financial benefit of the incremental QREs for smaller companies.

B. Comparison with Method B (Alternative Simplified Credit – ASC)

Method B provides a structurally simpler alternative, aligning the state benefit directly with the federal Alternative Simplified Credit (ASC) calculation, as described under IRC $\S 41(c)(5)$.6

  • Method B General Rate: For large businesses, Method B offers a credit equal to 50% of Delaware’s apportioned share of the taxpayer’s federal R&D tax credit, calculated using the ASC method.2
  • Method B Small Business Rate: For small businesses, this rate is also doubled, allowing them to claim 100% of Delaware’s apportioned share of the federal ASC.1
  • Apportionment Detail: The statute precisely defines Delaware’s apportioned share: it is the full federal ASC amount multiplied by a percentage equal to the ratio of the taxpayer’s Delaware QREs for the taxable year to their total qualified research and development expenses (QREs) worldwide for the taxable year.1

C. Strategic Modeling: Choosing the Optimal Method

The independence of the Delaware election means that the selection is driven purely by which method yields the maximum refundable credit for that specific tax year.

  • When Method A (10% General Rule) is Preferable: This method tends to be superior when a taxpayer has a history of relatively low R&D spending compared to gross receipts (resulting in a low FBP) but has experienced a steep, recent surge in QREs. A low Base Amount maximizes the “excess” spending, potentially pushing the benefit up to the 5% effective rate cap (10% of the 50% floor).4
  • When Method B (50% ASC) is Preferable: Method B is often favored by businesses with fluctuating QREs or those without the decades of historical data required to manage the FBP calculation effectively. The ASC base is defined simply as 50% of the average QREs from the three preceding tax years, providing a modern, less complex benchmark.9

Table Title: Strategic Comparison of Delaware R&D Credit Calculation Methods

Feature Method A: 10% General Rule (Large) Method A: 20% Rule (Small) Method B: 50% ASC (Large) Method B: 100% ASC (Small)
Credit Rate Applied 10% 20% 50% of Apportioned Federal ASC 100% of Apportioned Federal ASC
Calculation Base Excess QREs over Base Amount Excess QREs over Base Amount Apportioned Federal ASC Apportioned Federal ASC
Base Calculation Method 4-Year Fixed-Base Percentage (RRC Style) 3 4-Year Fixed-Base Percentage (RRC Style) 3 3-Year QRE Average (ASC Style) 3-Year QRE Average (ASC Style)
Gross Receipts Limit N/A (Standard) $\le \$20$ Million Average Annual Gross Receipts 6 N/A (Standard) $\le \$20$ Million Average Annual Gross Receipts 6
Refundability Fully Refundable 5 Fully Refundable 5 Fully Refundable 5 Fully Refundable 5

VI. Illustrative Example: Calculation of the 10% R&D Credit (Method A)

This numerical example demonstrates the mandatory sequence and application of the statutory constraints for a standard, non-small business taxpayer using the 10% General Rule.

A. Assumptions and Input Data

Scenario: Taxpayer Beta (a large entity) is calculating its Delaware R&D credit for the current year (Credit Year 5). The company has experienced significant recent growth in R&D spending.

Historical Data (Prior 4 Years: Y1-Y4) Amount
Total Delaware QREs (Line 1) $\$ 1,500,000$
Total Delaware Gross Receipts (Line 2) $\$ 40,000,000$
Current Year Data (Credit Year 5) Amount
Current Year Delaware QREs (Line 6) $\$ 1,000,000$

B. Step-by-Step Calculation Walkthrough (Form 2070AC, Method A)

The calculation follows the structure of Part B, Method A, on Delaware Form 2070AC.3

Table Title: Example Calculation of the 10% General Rule (Method A)

Form 2070AC Line Calculation Step Input/Formula Result
1. Total Prior 4-Year Delaware QREs Input $\$ 1,500,000$
2. Total Prior 4-Year Delaware Gross Receipts Input $\$ 40,000,000$
3. Delaware Fixed-Base Percentage (FBP) Line 1 $\div$ Line 2 $1,500,000 / 40,000,000 = **3.75\%**$
4. Average Annual Gross Receipts (AAGR) Line 2 $\div$ 4 Years $40,000,000 / 4 = **\$ 10,000,000**$
5. Delaware Base Amount Line 3 $\times$ Line 4 $3.75\% \times \$ 10,000,000 = **\$ 375,000**$
6. Current Year Delaware QREs Input $\$ 1,000,000$
7. Excess QREs Line 6 – Line 5 $\$ 1,000,000 – \$ 375,000 = **\$ 625,000**$
8. Statutory 50% Floor Line 6 $\times$ 50% $\$ 1,000,000 \times 50\% = **\$ 500,000**$
9. Credit-Earning Base Smaller of Line 7 or Line 8 $ 500,000
10. Delaware R&D Tax Credit (10% Rate) Line 9 $\times$ 10% $\$ 500,000 \times 10\% = **\$ 50,000**$

C. Analysis of the Limiting Factor

In this scenario, Taxpayer Beta’s current-year R&D expenditures significantly exceeded its historically low Base Amount (Line 7 calculated $\$ 625,000$ of excess). However, the critical limiting factor was the statutory 50% floor, which limited the credit-earning base to only $\$ 500,000$ (Line 8). The credit is ultimately based on the $\$ 500,000$ figure.4

This outcome underscores that the 50% floor is a crucial, non-negotiable component of the General Rule designed to cap the maximum benefit, even when historical spending is relatively low. The resulting $\$ 50,000$ credit, while fully refundable, represents an effective rate of only 5% of the total current-year Delaware QREs. This outcome reinforces the necessity for rigorous annual modeling, as Method B might have provided a higher credit if the taxpayer’s federal ASC calculation base was more favorable.

VII. Conclusion and Strategic Takeaways

The Delaware R&D Tax Credit’s 10% General Rule (Method A) offers a powerful refundable incentive for businesses making qualified investments in the state. Its structure, which incorporates the complex historical benchmarking methodology of the federal RRC, is uniquely paired with the financial advantage of full refundability. Taxpayers must navigate the intricacies of calculating the Fixed-Base Percentage and the strict application of the 50% statutory floor.

Actionable Strategic Recommendations

  1. Mandatory Annual Method Comparison: Taxpayers must strategically model both Method A (10% General Rule) and Method B (50% ASC) every year, as the independent election allows for choosing the method that yields the highest refundable credit, regardless of the federal choice.6
  2. Strict Adherence to Documentation Standards: The calculation, particularly for Method A, requires complex allocation of historical QREs and Gross Receipts specifically to Delaware sources over a four-year period.3 Comprehensive documentation supporting these allocations, alongside the required Federal Form 6765, is essential for audit defense.3
  3. Prioritize the September 15th Deadline: Given the credit’s full refundability, securing the cash payout is critical. Taxpayers must treat the September 15th filing deadline for DOR Form 2070AC as a mandatory, hard compliance date separate from other tax deadlines.5
  4. Monitor the Gross Receipts Threshold: Growing businesses must vigilantly track their four-year average annual gross receipts relative to the $\$20$ million threshold. Exceeding this limit results in a significant reduction of the credit rate, moving the taxpayer from the highly favorable 20% or 100% rates down to the standard 10% or 50% rates.6 Preparation for this transition is crucial for long-term tax planning.

Are you eligible?

R&D Tax Credit Eligibility AI Tool

Why choose us?

directive for LBI taxpayers

Pass an Audit?

directive for LBI taxpayers

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

Never miss a deadline again

directive for LBI taxpayers

Stay up to date on IRS processes

Discover R&D in your industry

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

R&D Tax Credit Training for CPAs

directive for LBI taxpayers

Upcoming Webinars

R&D Tax Credit Training for CFPs

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

R&D Tax Credit Training for SMBs

water tech

Upcoming Webinars

Choose your state

find-us-map